Nephrol Dial Transplant (1999) 14: 2898-2902
© 1999 European Renal Association-European Dialysis and Transplant Association
Endothelial nitric oxide synthase gene polymorphism in intron 4 affects the progression of renal failure in non-diabetic renal diseases
Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
Correspondence and offprint requests to: Professor Akio Koyama MD, Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, 1–1–1 Ten-nodai, Tsukuba, Ibaraki 305–8575, Japan.
Background. Nitric oxide is a very potent regulator of intrarenal haemodynamics and is thought to be an important factor in the deterioration of renal function. Our study sought to verify the hypothesis that endothelial nitric oxide synthase (ecNOS) gene polymorphism in intron 4 might have some relevance to progression in chronic renal failure.
Methods. We studied the frequencies of gene polymorphism of ecNOS intron 4 in patients with end-stage renal disease (302 cases) and compared it with that of healthy subjects (248 cases). ecNOS genotypes were determined by the polymerase chain reaction, followed by agarose gel electrophoresis.
Results. Two alleles of ecNOS intron 4, labelled a and b could be detected; a has four and b has five tandem 27-bp repeats. The frequencies of ecNOS4b/b, ecNOS4b/a, ecNOS4a/a genotypes were 81.0% (201/248), 19.0% (47/248), 0.0% (0/248) in the control group, and 74.8% (226/302), 23.5% (71/302), l.7% (5/302) in all the patients, 72.7% (168/231), 25.1% (58/231), 2.2% (5/231) in the group with end-stage renal diseases, excluding diabetic nephropathy (non-DM group), and 81.7% (58/71), 18.3% (13/71), 0.0% (0/71) in diabetic nephropathy (DM group) respectively. The frequency of the ecNOS4a (ecNOSb/a, and ecNOSa/a) in all the patients and in the non-DM group were significantly higher than that in the control group (P=0.021; P=0.0096 respectively). In contrast, there was no significant difference in the frequencies of ecNOS genotypes between the DM group and the control group (P=0.81).
Conclusion. Among the frequencies of ecNOS intron 4 gene polymorphism, a allele displayed a significantly higher frequency in cases with end-stage renal failure (ESRF) not caused by diabetic nephropathy. ecNOS gene polymorphism in intron 4 appears, therefore, to affect the progression of renal failure in non- diabetic renal diseases, but the same conclusion could not be drawn in diabetic nephropathy.
Keywords: end-stage renal failure; endothelial nitric oxide synthase; gene polymorphism; polymerase chain reaction
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  V. Vazgiourakis, P. Sidiropoulos, G. Bertsias, E. Koutsounaki, E. Fragouli, A. Raptopoulou, H. Kritikos, D.T. Boumpas, and G.N. Goulielmos Association of the nitric oxide synthase (eNOS) gene polymorphism with increased risk for both lupus glomerulonephritis and rheumatoid arthritis in a single genetically homogeneous population Lupus, November 1, 2007; 16(11): 867 - 874. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Stratta, F. Bermond, S. Guarrera, C. Canavese, S. Carturan, A. Dall'Omo, G. Ciccone, L. Bertola, G. Mazzola, E. Fasano, et al. Interaction between gene polymorphisms of nitric oxide synthase and renin-angiotensin system in the progression of membranous glomerulonephritis Nephrol. Dial. Transplant., March 1, 2004; 19(3): 587 - 595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Persu, M. S. Stoenoiu, T. Messiaen, S. Davila, C. Robino, O. El-Khattabi, M. Mourad, S. Horie, O. Feron, J. -L. Balligand, et al. Modifier effect of ENOS in autosomal dominant polycystic kidney disease Hum. Mol. Genet., February 1, 2002; 11(3): 229 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Degen, S. Schmidt, and E. Ritz A polymorphism in the gene for the endothelial nitric oxide synthase and diabetic nephropathy Nephrol. Dial. Transplant., January 1, 2001; 16(1): 185 - 185. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Suzuki, S. Nagase, S. Kikuchi, Y. Wang, and A. Koyama Association of a Missense Glu298Asp Mutation of the Endothelial Nitric Oxide Synthase Gene with End Stage Renal Disease Clin. Chem., November 1, 2000; 46(11): 1858 - 1860. [Full Text] [PDF]
|
|